Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
AI Summary
US President Donald Trump announced the final phase of pharmaceutical tariffs, allowing generic medicines from India to enter the US duty-free until August 1, 2028. This move impacts global trade relations and pharmaceutical markets.
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.
Politics Markets Commodities Donald Trump pharmaceutical tariffs India generic medicines US trade policy